Dr Mariane Melo, Medical Director
We’re excited to share that DemDx has been selected for the Artificial Intelligence in Health and Care Award to accelerate the adoption of Ophthalmology triage platform and improve access to eye care for hundreds of thousands of people in the UK.
We’re excited to share that DemDx has been selected for the Artificial Intelligence in Health and Care Award to accelerate the development and adoption of Ophthalmology triage platform and improve access to eye care for hundreds of thousands of people in the UK.
The Secretary of State for Health and Social Care, Matt Hancock and NHSx and announced on the 8th of September that DemDx had been selected as one of several recipients chosen from a pool of over 530 applicants. The companies will be awarded a share of £50 million from a total pot of £140 million over three years to deploy technologies to NHS sites and transform care. The award is run by the Accelerated Access Collaborative (AAC) in partnership with NHSX and the National Institute of Health Research (NIHR).
Health Secretary Matt Hancock said:
“The NHS has always spearheaded world-leading technologies that can transform and save lives, so it is vital we continue to harness the full potential of modern digital advances to help patients living with life-limiting illness and support our hardworking NHS staff.
During the pandemic we have all seen the positive impact new technology can have – from our next generation rapid testing, to our machine-learning tools helping the NHS predict where beds and oxygen are needed – and I’m determined we continue down this path.
Today’s funding will ensure the NHS can continue to fast-track pioneering artificial intelligence to the frontline, freeing up clinicians’ time and saving lives.”
The award will be used to fund further develop and test our AI Ophthalmology Triage platform which will deliver reduced waiting time for thousands of patients, bring operational efficiency to the NHS and transform eye services of the future.
We are incredibly pleased to be a part of the NHS AI lab, and be part of the groundbreaking digital transformation in healthcare.
The National Institute for Health Research (NIHR) is the nation’s largest funder of health and care research. The NIHR:
Funds, supports and delivers high-quality research that benefits the NHS, public health and social care
Engages and involves patients, carers and the public in order to improve the reach, quality and impact of research
Attracts, trains and supports the best researchers to tackle the complex health and care challenges of the future
Invests in world-class infrastructure and a skilled delivery workforce to translate discoveries into improved treatments and services
Partners with other public funders, charities and industry to maximise the value of research to patients and the economy
The NIHR was established in 2006 to improve the health and wealth of the nation through research, and is funded by the Department of Health and Social Care. In addition to its national role, the NIHR supports applied health research for the direct and primary benefit of people in low- and middle-income countries, using UK aid from the UK government. @NIHRresearch
Notes to editors
DemDx is a UK-based digital medical information business used by medical professionals in over 160 countries worldwide. We support healthcare professionals to assess patients when they first present for medical advice in either a clinic, emergency department, or primary-care setting. DemDx helps medical professionals to improve clinical reasoning and diagnostic confidence. The web, tablet, and smartphone app includes clinical algorithms covering over 10,000 different presentations for 1,300 clinical conditions.
For further information please contact email@example.com
For updates follow DemDx on social media